Acorda Therapeutics Inc (NASDAQ:ACOR)

26.05
Delayed Data
As of Feb 23
 -0.35 / -1.33%
Today’s Change
13.60
Today|||52-Week Range
33.00
+21.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-18.9M-8.2M-25.2M--
 
 
 
 
Depreciation5.6M6.1M5.8M--
 
 
 
 
Total Other Cash Flow21.5M23.2M47.8M--
 
 
 
 
Funds From Operations3.6M24.1M46.8M--
 
 
 
 
Funds From/For Other Operating Expenses29.0M13.9M-4.6M--
 
 
 
 
Net Cash Flow - Operating Activities-25.4M10.3M51.4M--
 
 
 
 
 
InvestingCapital Expenditures-5.8M-3.0M-1.6M--
 
 
 
 
Fixed Asset Disposal2.7M0.000.00--
 
 
Net Cash Flow Investing-3.1M-3.1M-1.7M--
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----0.00----
Long Term Debt Reduction-2.2M-184.0K0.00--
 
 
 
Net Proceeds Stock Sale5.5M0.001.5M--
 
 
 
Common Preferred Redeemed0.00-60.0K0.00--
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing3.2M-244.0K1.5M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash361.0K545.0K154.0K--
 
 
 
 
 
Net Change In Cash-25.3M6.9M51.2M0.00